recommended for patients with hand OA. A single trial suggested analgesic efficacy of chondroitin sulfate, without evidence of harm, in hand OA. Hydroxychloroquine is strongly recommended against in patients with knee, hip, and/or hand OA. Well-designed RCTs of hydroxychloroquine, conducted in the subset of patients with erosive hand OA, have demonstrated no efficacy. Methotrexate is strongly recommended against in patients with knee, hip, and/or hand OA. Well-designed RCTs of methotrexate, conducted in the subset of patients with erosive hand OA, have demonstrated no efficacy. Intraarticular hyaluronic acid injections are conditionally recommended against in patients with knee and/or first CMC joint OA and strongly recommended against in patients with hip OA. In prior systematic reviews, apparent benefits of hyaluronic acid injections in OA have been reported. These reviews have not, however, taken into account the risk of bias of the individual primary studies. Our review showed